TRV GP III’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,185,291
| Closed | -$24.6M | – | 3 |
|
|
2023
Q1 | $24.6M | Sell |
3,185,291
-2,243,642
| -41% | -$17.3M | 29.6% | 2 |
|
|
2022
Q4 | $33.1M | Hold |
5,428,933
| – | – | 25.95% | 3 |
|
|
2022
Q3 | $32.1M | Sell |
5,428,933
-962,243
| -15% | -$5.7M | 14.03% | 3 |
|
|
2022
Q2 | $37.8M | Hold |
6,391,176
| – | – | 15.45% | 3 |
|
|
2022
Q1 | $48.7M | Hold |
6,391,176
| – | – | 13.21% | 3 |
|
|
2021
Q4 | $17.3M | Hold |
6,391,176
| – | – | 4.33% | 5 |
|
|
2021
Q3 | $16.8M | Hold |
6,391,176
| – | – | 3.19% | 7 |
|
|
2021
Q2 | $26.4M | Hold |
6,391,176
| – | – | 4.61% | 6 |
|
|
2021
Q1 | $30.1M | Hold |
6,391,176
| – | – | 3.81% | 7 |
|
|
2020
Q4 | $45.7M | Hold |
6,391,176
| – | – | 3.92% | 6 |
|
|
2020
Q3 | $68.2M | Hold |
6,391,176
| – | – | 5.73% | 5 |
|
|
2020
Q2 | $80.7M | Hold |
6,391,176
| – | – | 11.77% | 4 |
|
|
2020
Q1 | $58.5M | Hold |
6,391,176
| – | – | 15.91% | 3 |
|
|
2019
Q4 | $89.2M | Hold |
6,391,176
| – | – | 39.37% | 2 |
|
|
2019
Q3 | $110M | Hold |
6,391,176
| – | – | 62.32% | 1 |
|
|
2019
Q2 | $174M | Hold |
6,391,176
| – | – | 73.96% | 1 |
|
|
2019
Q1 | $122M | Hold |
6,391,176
| – | – | 59.92% | 1 |
|
|
2018
Q4 | $60.1M | Hold |
6,391,176
| – | – | 50.34% | 1 |
|
|
2018
Q3 | $121M | Sell |
6,391,176
-1,500,000
| -19% | -$28.4M | 54% | 1 |
|
|
2018
Q2 | $154M | Sell |
7,891,176
-1,500,000
| -16% | -$29.3M | 51.35% | 1 |
|
|
2018
Q1 | $176M | Hold |
9,391,176
| – | – | 63.52% | 1 |
|
|
2017
Q4 | $156M | Buy |
+9,391,176
| New | +$156M | 54.58% | 1 |
|